KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of CDNA
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Is CareDx stock still a buy after falling -5.26% on Thursday?
(Updated on Apr 25, 2024)

Sell candidate since Apr 03, 2024 Loss -24.70% PDF

The CareDx stock price fell by -5.26% on the last day (Thursday, 25th Apr 2024) from $7.98 to $7.56. During the last trading day the stock fluctuated 3.59% from a day low at $7.53 to a day high of $7.80. The price has fallen in 7 of the last 10 days and is down by -17.29% for this period. Volume has increased on the last day by 12 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 530 thousand shares were bought and sold for approximately $4.01 million.

Given the current horizontal trend, you can expect CareDx stock with a 90% probability to be traded between $7.47 and $11.84 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

CDNA Signals & Forecast

There are few to no technical positive signals at the moment. The CareDx stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $8.09 and $9.57. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, March 04, 2024, and so far it has fallen -37.42%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for CareDx stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.270 between high and low, or 3.59%. For the last week, the stock has had daily average volatility of 5.29%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CDNA) For The Upcoming Trading Day Of Friday 26th

For the upcoming trading day on Friday, 26th we expect CareDx to open at $7.63, and during the day (based on 14 day Average True Range), to move between $7.01 and $8.11, which gives a possible trading interval of +/-$0.548 (+/-7.25%) up or down from last closing price. If CareDx takes out the full calculated possible swing range there will be an estimated 14.50% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $8.28, some $0.720 (9.52%) from the current price of $7.56, our system finds the risk reward not very attractive.

Is CareDx stock A Buy?

CareDx holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

Current score: -4.485 Sell Candidate Upgraded

Predicted Opening Price for CareDx of Friday, April 26, 2024

Fair opening price April 26, 2024 Current price
$7.63 ( 0.93%) $7.56

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for CDNA

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 7.90 4.50 %
R2 7.80 3.13 %
R1 7.73 2.29 %
Current price: 7.56
Support S1 7.53 -0.438 %
S2 7.46 -1.28 %
S3 7.36 -2.65 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 9.02 19.31 %
R2 8.56 13.23 %
R1 8.28 9.52 %
Current price 7.56
Support S1 0 .
S2 0 .
S3 0 .

FAQ

What is the symbol for CareDx Stock and on which exchange is it traded?
The symbol for CareDx is CDNA and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell CareDx Stock?
CareDx holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. We have upgraded our analysis conclusion for this stock since the last evaluation from a Strong Sell to a Sell candidate.

How to buy CareDx Stock?
CareDx Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy CareDx Stock.

What's the current price of CareDx Stock?
As of the end of day on the Apr 25, 2024, the price of an CareDx (CDNA) share was $7.56.

What is the 52-week high and low for CareDx Stock?
The 52-week high for CareDx Stock is $12.91 and the 52-week low is $4.80.

What is the market capitalization of CareDx Stock?
As of the Apr 25, 2024, the market capitalization of CareDx is 391.445M.

When is the next earnings date for CareDx?
The upcoming earnings date for CareDx is May 08, 2024.
Click to get the best stock tips daily for free!

About CareDx

CareDx CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The co... CDNA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT